[
  {
    "ts": null,
    "headline": "Chinese start-up breaks US monopoly in 3D imaging of biomolecules, aims for IPO in 2027",
    "summary": "Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027 after selling its first self-developed product this year, according to CEO Allen Guo Chunlong. The company focuses on cryo-electron microscopy (Cryo-EM), a technique that involves firing beams of electrons at flash-frozen specimens to capture thousands of images. The images are then used to reconstruct precise three-dimensional str",
    "url": "https://finnhub.io/api/news?id=188cc62bbd9bc9b6af5ba85681bad86212390c3ee32d7c16ae0fbf92070a8124",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758105000,
      "headline": "Chinese start-up breaks US monopoly in 3D imaging of biomolecules, aims for IPO in 2027",
      "id": 136787571,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027 after selling its first self-developed product this year, according to CEO Allen Guo Chunlong. The company focuses on cryo-electron microscopy (Cryo-EM), a technique that involves firing beams of electrons at flash-frozen specimens to capture thousands of images. The images are then used to reconstruct precise three-dimensional str",
      "url": "https://finnhub.io/api/news?id=188cc62bbd9bc9b6af5ba85681bad86212390c3ee32d7c16ae0fbf92070a8124"
    }
  }
]